Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lower limb revascularization in diabetics

F Citterio1, M Castagneto

  • 1Cattedra di Chirurgia Sostitutiva e dei Trapianti d'Organo, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Roma, Italy.

Rays
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 1506-1514, 2007.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

Periodontitis and Accelerated Biological Aging: A Geroscience Approach.

Journal of dental research·2021
Same author

Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms.

Urolithiasis·2018
Same author

Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.

Transplantation proceedings·2017
Same author

N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney.

Transplantation proceedings·2015
Same author

Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment.

Transplantation proceedings·2015

Peripheral revascularization offers a high limb salvage rate for diabetic patients with critical lower limb ischemia. This approach, including bypass and less invasive endovascular techniques, achieves a 5-year limb salvage rate of 92% in diabetic individuals.

Area of Science:

  • Vascular Surgery
  • Diabetic Complications
  • Lower Limb Ischemia

Background:

  • Critical lower limb ischemia in diabetics presents complex challenges due to systemic and local factors.
  • Amputation is often the only recourse for diabetic patients with ischemic-necrotic lesions.
  • Arterial disease in diabetics progresses through stages: claudication, rest pain, and ulcerative-necrotic lesions.

Purpose of the Study:

  • To review treatment modalities for critical lower limb ischemia in diabetic patients.
  • To highlight the efficacy of revascularization in limb salvage for this patient population.
  • To compare traditional surgical bypass with newer endovascular techniques.

Main Methods:

  • Conservative management involves metabolic control, anemia correction, risk factor management, debridement, and antibiotics.

Related Experiment Videos

  • Diagnostic angiography guides revascularization decisions when conservative therapy fails after six weeks.
  • Revascularization includes traditional bypass surgery (saphenous vein grafts) and endovascular interventions (balloons, atherotomes, stents).

    • Main Results:

    • Conservative treatment focuses on optimizing patient condition and local wound care.
    • Failure to heal lesions after optimal conservative therapy indicates significant ischemia requiring revascularization.
    • Peripheral revascularization techniques, both surgical and endovascular, are employed in specialized centers.

    Conclusions:

    • Peripheral revascularization is crucial for limb salvage in diabetics with critical lower extremity ischemia.
    • Endovascular techniques offer less invasive alternatives to traditional bypass surgery.
    • A 5-year limb salvage rate of 92% is achievable with current peripheral revascularization strategies in diabetic patients.